Funda Meric-Bernstam

Funda Meric-Bernstam, M.D., is the Chair of the Department of Investigational Cancer Therapeutics, the Phase 1 Program at The University of Texas MD Anderson Cancer Center. She is a widely recognized Phase 1 trial expert and experimental therapeutics researcher in oncology. Dr. Meric-Bernstam’s clinical research is focused on novel therapeutics, combination therapies, and biomarkers to predict and monitor drug response. Dr. Meric-Bernstam received her MD from the Yale University School of Medicine.